Praxis Precision Medicines
PRAX
PRAX
134 hedge funds and large institutions have $1.09B invested in Praxis Precision Medicines in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 44 increasing their positions, 45 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 45
1.44% less ownership
Funds ownership: 107.68% → 106.24% (-1.4%)
Holders
134
Holding in Top 10
5
Calls
$24M
Puts
$20M
Top Buyers
| 1 | +$57.4M | |
| 2 | +$23.8M | |
| 3 | +$14.4M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$11M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$10.6M |
Top Sellers
| 1 | -$27.3M | |
| 2 | -$18.2M | |
| 3 | -$16.1M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$16.1M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$15.7M |